|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 513/04 | |
| A61K 31/444 | |||
| A61P 7/02 | |||
| C07B 61/00 |
| (11) | Number of the document | 3109251 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15752746.6 |
| Date of filing the European patent application | 2015-02-13 | |
| (97) | Date of publication of the European application | 2016-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/054001 |
| Date | 2015-02-13 |
| (87) | Number | WO 2015/125710 |
| Date | 2015-08-27 |
| (30) | Number | Date | Country code |
| 2014028266 | 2014-02-18 | JP |
| (72) |
UEDA, Tsuyoshi, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426,
JP
|
| (54) | METHOD FOR PRODUCING INHIBITOR OF ACTIVATED BLOOD COAGULATION FACTOR X (FXA) |
| METHOD FOR PRODUCING INHIBITOR OF ACTIVATED BLOOD COAGULATION FACTOR X (FXA) |